TC BioPharm PLC (NASDAQ:TCBP) announced that it is developing a streamlined and scaled-up manufacturing process which will increase its treatments capacity from 52 patient treatments per year to more ...
Source LinkTC BioPharm PLC (NASDAQ:TCBP) announced that it is developing a streamlined and scaled-up manufacturing process which will increase its treatments capacity from 52 patient treatments per year to more ...
Source Link
Comments